FELLOW NEWS

Manish Ayushman, a PhD student in bioengineering, has watched more than a thousand hours of microscopic footage of stem cells in the lab. At first, the cells seemed like they weren’t doing much of anything. But when Ayushman looked a little more closely, he noticed they were moving ever so slightly – turning and pulsing to a languid tempo.

When he sped up the footage, the movements became clearer: Each stem cell appeared to be shimmying and shaking with purpose.

In a paper published Nov. 1 in Nature Materials, Ayushman and Stanford Medicine colleagues described this previously unknown type of cell movement, which they’ve named cell tumbling. Unlike known types of cell movement, such as spreading and migration, which take hours to days, cell tumbling is relatively quick, taking seconds to minutes.

Microgravity is known to alter the muscles, bones, the immune system and cognition, but little is known about its specific impact on the brain. To discover how brain cells respond to microgravity, Scripps Research scientists, in collaboration with the New York Stem Cell Foundation, sent tiny clumps of stem-cell derived brain cells called “organoids” to the International Space Station (ISS).

Surprisingly, the organoids were still healthy when they returned from orbit a month later, but the cells had matured faster compared to identical organoids grown on Earth — they were closer to becoming adult neurons and were beginning to show signs of specialization. The results, which could shed light on potential neurological effects of space travel, were published on October 23, 2024, in Stem Cells Translational Medicine.

The recent nationwide alert about E. coli-laced organic carrots is just the latest example that our food safety isn’t guaranteed. Now a research team at UT Dallas is exploring a way that people can do a final check for contaminants—right in their own homes.

From contaminated carrots to harmful hamburger, tainted food has caused sickness and even death for decades—with E. coli-laced organic carrots the latest item to alarm Americans nationwide. Now a research team at the University of Texas at Dallas is developing a tool for consumers to use right in their own homes to add an extra level of food safety.

The researchers—led by Dr. Shalini Prasad, department head of bioengineering at UTD’s Erik Jonsson School of Engineering and Computer Science—is developing sensors that could make it possible for consumers to detect contaminants in food and water “within minutes,” the university said.

Researchers at the University of Texas and the University of California, Los Angeles (UCLA) say they have created a liquid ink that can be directly printed onto a patient’s scalp to measure brain activity, offering an alternative to traditional electroencephalography (EEG). The new technology, detailed in the journal Cell Biomaterials, is part of ongoing research into electronic tattoos (e-tattoos) and their potential to improve both clinical diagnostics and brain-computer interface applications.

“Our innovations in sensor design, biocompatible ink, and high-speed printing pave the way for future on-body manufacturing of electronic tattoo sensors, with broad applications both within and beyond clinical settings,” said lead researcher Nanshu Lu, PhD, whose lab at the University of Texas at Austin focuses on the development of bio-integrated electronics.

A study from Johns Hopkins University, published in Biophotonics Discovery, examined how skin tone affects the accuracy of photoacoustic imaging (PAI), a technology gaining traction in breast cancer diagnostics, especially in situations where traditional mammography is insufficient. The study shows how image reconstruction methods and laser wavelengths influence the visibility of cancerous targets in patients with diverse skin tones and suggests practical solutions to improve equity in diagnostics.

Photoacoustic imaging is a hybrid imaging technique that combines light and sound. Light pulses are transmitted into the body and absorbed by structures like blood vessels, which then undergo thermal expansion and generate sound waves. Ultrasound detectors capture these waves to create detailed images.

An international team led by researchers at the University of Toronto and the Broad Institute of MIT and Harvard has assembled the first large-scale, publicly available map to show the impact of mutations on where proteins end up in the cell.

The team developed a high-throughput imaging platform to assess the influence of nearly 3,500 mutations on protein location. They found that roughly one in six disease-causing mutations led to proteins ending up in the wrong location in the cell.

University of Florida Distinguished Professor Christine Schmidt has been elected to the National Academy of Medicine. This prestigious honor follows her election earlier this year to the National Academy of Engineering, making her one of the few exceptional individuals to be recognized by both academies.

Election to the National Academy of Medicine recognizes outstanding professional achievement and commitment to service in the fields of health and medicine. The Academy announced the names of its 100 new members today during its annual meeting in Washington, D.C.

Schmidt, the Pruitt Family Endowed Chair in the J. Crayton Pruitt Family Department of Biomedical Engineering, was selected for her “outstanding leadership, pioneering research, and clinical translation in neural tissue engineering and wound healing.”

Two UC San Francisco faculty members have been elected to the National Academy of Medicine (NAM) this year, one of the highest honors in the field of health and medicine.

NAM recognizes individuals who have demonstrated outstanding professional achievements and commitment to service in the medical sciences, health care and public health. The academy elects no more than 100 members a year.

Alicia Fernandez, MD, professor of medicine, was recognized for her work on how language and literacy barriers impact patient care and outcomes; and Nola M. Hylton, PhD, a professor of radiology and biomedical imaging was recognized for developing magnetic resonance imaging (MRI) for breast cancer.

After several years of investigating focused ultrasound as a tool in treating Alzheimer’s, the field took a big leap forward this year.

Elisa Konofagou, PhD, a biomedical engineer who runs the Ultrasound and Elasticity Imaging Laboratory at Columbia University in the City of New York, published the results of her team’s groundbreaking research in July, demonstrating their noninvasive, fully portable system for delivering drugs and immunotherapy to patients with Alzheimer’s disease.

This after West Virginia University researchers established earlier this year how focused ultrasound can be used to sneak medication past the blood-brain barrier, reducing amyloid beta plaques.

People with diabetes take insulin to lower high blood sugar. However, if glucose levels plunge too low—from taking too much insulin or not eating enough sugar—people can experience hypoglycemia, which can lead to dizziness, cognitive impairment, seizures or comas. Emergency treatment with the hormone glucagon (GCG) may be needed. Researchers at the University of California, Los Angeles (UCLA) have now developed a method to encapsulate glucagon in glucose-responsive micelles that only release the hormone when blood glucose levels become too low. Tests in mice confirmed that the injected nanocapsules activated only when blood sugar levels dropped dangerously low, and quickly restored glucose levels.

Research leads Andrea Hevener, PhD, Heather Maynard, PhD, and colleagues reported on their developments in ACS Central Science, in a paper titled “A Glucose-Responsive Glucagon-Micelle for the Prevention of Hypoglycemia.

Barbara Shinn-Cunningham has been named Carnegie Mellon University’s Glen de Vries Dean of the Mellon College of Science (MCS), effective Jan. 1, 2025.

Shinn-Cunningham, who will be the eighth dean to lead MCS, joined Carnegie Mellon in 2018 as the founding director of the Neuroscience Institute and the George A. and Helen Dunham Cowan Professor of Auditory Neuroscience. She holds courtesy appointments in the departments of Psychology, Biomedical Engineering and Electrical and Computer Engineering.

“Dr. Shinn-Cunningham’s appointment as the next dean of MCS marks an exciting next chapter for the college,” said Carnegie Mellon Provost James H. Garrett Jr. “Her distinguished research background and proven leadership skills position her to propel the future of science initiative forward and guide MCS toward even greater heights.

Nearly one third of concussions in professional American football are due to impacts from the facemask, a part of the helmet that has remained mostly unchanged in the last decade. In a new study presented at the International Research Council on Biomechanics of Injury conference today, researchers used data collected from instrumented mouthpieces worn by players in the National Football League (NFL) that measured head motion and found that facemasks are the most frequent location of impact on a player’s helmet in a subset of high severity impacts. The study findings suggest that facemask enhancements could help protect players and minimize injury risk.

In recent years, there has been a concerted effort to reduce the number of concussions sustained by professional American football players, with one important strategy involving engineering research to redesign helmets to better protect these athletes.

Columbia team engineers a model of the human heart tissue that demonstrates how autoantibodies directly affect heart disease in lupus patients

Cardiovascular disease is the leading cause of death in patients suffering from lupus, an autoimmune disease in which our immune system attacks our own tissues and organs, the heart, blood, lung, joints, brain, and skin. Lupus myocarditis–inflammation of the heart muscle– can be very serious because the inflammation alters the regularity of the rhythm and strength of the heartbeat. However, the mechanisms underlying this complex disease are poorly understood and difficult to study.

A long-standing question about lupus is why some patients develop myocarditis while others remain unaffected. And why the clinical manifestations of affected patients range so dramatically, from no symptoms at all to severe heart failure. Lupus is characterized by a large number of autoantibodies, immune proteins that mistakenly target a person’s own tissues or organs, with different specificities for various molecules. Like our genes, they may explain why different individuals experience different symptoms.

The Journal of Neurosurgery has published online a study by the Wisconsin National Primate Research Center at the University of Wisconsin, Madison regarding a novel cell transplantation approach being used for delivery of ANPD001, an autologous, dopaminergic neuronal cell replacement under investigation by Aspen Neuroscience as a potential treatment for Parkinson’s Disease.

The study by the Wisconsin National Primate Research Center demonstrated the safety and feasibility of the treatment approach for ANPD001 in non-human primates. Aspen is currently investigating ANPD001 in the ASPIRO trial, a first-in-human, open-label Phase 1/2a clinical trial in people with moderate to severe Parkinson’s disease.

UD research aims to improve the lives of those with limb loss

John Horne lost his right leg to bone cancer when he was a freshman in high school. This intensely personal experience spawned his career and passion for advocating for those with limb loss. The president of Independence Prosthetics-Orthotics on the University of Delaware’s Science, Technology, and Advanced Research (STAR) Campus has seen prosthetics improve significantly since his limb loss and since he was an undergraduate student at UD, interning at Nemours Children’s Health, where he poured prosthetic molds.

Now, Horne is part of pioneering research led by George W. Laird Professor of Mechanical Engineering Jill Higginson in the Neuromuscular Biomechanics Laboratory along with co-investigators Elisa Arch, associate professor of kinesiology and applied physiology, and Meg Sions, associate professor of physical therapy, in the College of Health Sciences. The study aims to test the potential of fabric-based sensors in monitoring load in individuals with limb loss, a development that could revolutionize the field of prosthetics and significantly improve the lives of those with limb loss.

Twelve Carle Illinois College of Medicine (CI MED) researchers have been chosen as part of the inaugural group of investigators probing the role of inflammation and the function of the immune system in disease, including one CI MED-based team examining inflammation’s role in female reproductive disorders.

The Chan Zuckerberg Biohub Chicago was announced in 2023 to leverage the expertise of researchers from a range of disciplines to develop technologies capable of making precise, molecular-level measurements of biological processes within human tissues. The longer-range goal is understanding and treating the inflammatory states that underlie many diseases.

I am pleased to announce that following a national search, Omolola “Lola” Eniola-Adefeso, PhD, has been named dean of the University of Illinois Chicago College of Engineering, effective Oct. 16, pending approval by the University of Illinois Board of Trustees.

Professor Eniola-Adefeso is a highly respected chemical and biomedical engineer with over 25 years of professional experience. An accomplished scholar, she has published more than 70 peer-reviewed publications and secured millions of dollars in federal research funding. Eniola-Adefeso has a strong track record of adopting an interdisciplinary approach to her work, and her entrepreneurial successes have resulted in three patent filings, with one patent currently being licensed to a biotech company. She also is highly recognized in the scientific community, as demonstrated by numerous national awards and her current leadership positions as the president of the American Institute for Medical and Biological Engineering and director of the American Institute of Chemical Engineers. She also participates on the National Academies Study Committee: Quadrennial Review of the National Nanotechnology Initiative.

Implanted stents have saved countless lives. A tiny metal mesh coil, stents keep arteries open for blood to flow that’s crucial to the body to function after a traumatic angioplasty or cardiac event.

That doesn’t mean they’re a perfected technology.

Stents themselves can also develop plaque due to the systemic nature of the same cardiovascular disease they were implanted to counteract. With cardiovascular disease the leading cause of death globally, according to the World Health Organization, the need for more effective stents has never been greater.

From chronic wounds to battlefield triage to heart surgery, this self-sticking bandage is designed to adapt to any body surface, internal or external, creating a bond stronger than current FDA-approved adhesives. The applications of this innovation are detailed in Nature Communications.

“Our patch mimics the skin’s expandability and flexibility, stretching as a person moves,” says principal investigator Juliane Nguyen, professor in the UNC Eshelman School of Pharmacy. “Normal bandages contract in one direction as they expand in another. Ours are designed to expand in both directions, preventing tissue damage and promoting adhesion.”

Alopecia areata (AA) is an autoimmune disease characterized by hair loss, which occurs when T cells of the immune system mistakenly attack hair follicles. To restore control over hyperactive immune cells, investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, and MIT developed a cutting-edge approach to deliver T cell regulators directly to sites of hair loss and halt autoimmune activity. Findings, published in Advanced Materials, demonstrated marked and lasting increases in hair regrowth in models of the disease.

Our immune system evolved to safeguard against the overactivation that occurs when it mistakenly attacks our own tissues, as seen in autoimmune conditions. In conditions like AA, the specialized cells known as Regulatory T cells (Tregs) fall short in protecting hair follicles. Current immunosuppressants used in AA target both T cells and Tregs, failing to address the core issue and increasing the risk of disease recurrence once treatment stops. Moreover, systemic immune therapy suppresses the entire immune system, leaving patients vulnerable to infections and malignancies.

New approach could enable patients to live pain-free without complications of diabetes

Northwestern University researchers have developed a new antioxidant biomaterial that someday could provide much-needed relief to people living with chronic pancreatitis.

The study was published today (June 7) in the journal Science Advances.

Before surgeons remove the pancreas from patients with severe, painful chronic pancreatitis, they first harvest insulin-producing tissue clusters, called islets, and transplant them into the vasculature of the liver. The goal of the transplant is to preserve a patient’s ability to control their own blood-glucose levels without insulin injections.

Scientists used an algorithm to mine ‘the entirety of the microbial diversity’ on Earth, speeding up antibiotic resistance research

A new study used machine learning to predict potential new antibiotics in the global microbiome, which study authors say marks a significant advance in the use of artificial intelligence in antibiotic resistance research.

The report, published Wednesday in the journal Cell, details the findings of scientists who used an algorithm to mine the “entirety of the microbial diversity that we have on earth – or a huge representation of that – and find almost 1m new molecules encoded or hidden within all that microbial dark matter”, said César de la Fuente, an author of the study and professor at the University of Pennsylvania. De la Fuente directs the Machine Biology Group, which aims to use computers to accelerate discoveries in biology and medicine.

New research addresses a gap in understanding how ketamine’s impact on individual neurons leads to pervasive and profound changes in brain network function.

Ketamine, a World Health Organization Essential Medicine, is widely used at varying doses for sedation, pain control, general anesthesia, and as a therapy for treatment-resistant depression. While scientists know its target in brain cells and have observed how it affects brain-wide activity, they haven’t known entirely how the two are connected. A new study by a research team spanning four Boston-area institutions uses computational modeling of previously unappreciated physiological details to fill that gap and offer new insights into how ketamine works.

“This modeling work has helped decipher likely mechanisms through which ketamine produces altered arousal states as well as its therapeutic benefits for treating depression,” says co-senior author Emery N. Brown, the Edward Hood Taplin Professor of Computational Neuroscience and Medical Engineering at The Picower Institute for Learning and Memory at MIT, as well as an anesthesiologist at Massachusetts General Hospital and a professor at Harvard Medical School.

Recently FDA-approved anti-amyloid monoclonal antibody therapy can potentially slow disease progression

PET-MRI offers a comprehensive approach to the evaluation and management of patients with Alzheimer’s disease (AD) and dementia, providing valuable insights into disease pathology, progression and treatment response. Its multi-modal imaging capabilities can enhance diagnostic accuracy and facilitate personalized patient care.

The recent FDA approvals of anti-amyloid monoclonal antibody therapies demonstrates the importance of PET-MRI to diagnose AD since this technology can simultaneously provide the required brain MRI for baseline safety as well as the required biomarker for beta-amyloid pathology.

The new research published in the journal Bioelectronic Medicine

One of the major functions of the immune system is to – through antibodies – fight infections. New findings from The Feinstein Institutes for Medical Research bioelectronic medicine scientists show that neurons that help sense pain and prevent illness, called sensory neurons, play an important role in regulating the production of antibodies.

The study published today in the journal Bioelectronic Medicine — an open-access journal and part of BMC Springer Nature — reveals how activating specific nerves using light stimulation, known as optogenetic activation, results in increased antibody responses, and suggests the potential for neuromodulation to improve antibody responses to fight diseases.

Revolutionary acousto-printing method can be used to circumvent invasive surgery, and has a wide array of potential applications.

A new drug delivery and tissue implantation technique utilizing ultrasound waves as an alternative to surgery has been developed in the Stem Cell and Tissue Engineering Lab of Prof. Shulamit Levenberg at the Technion-Israel Institute of Technology.

The technique allows for bioprinting live cells and tissues deep within the body using external soundwave irradiation.

Inflammatory bowel disease (IBD) is a complex condition that requires individualized care to meet the needs of the patient’s current disease state. With available medications sometimes causing serious side effects or losing their efficacy over time, many researchers have been exploring new, more targeted ways of delivering medications or other beneficial compounds, such as probiotics.

To address pitfalls in IBD treatment and drug delivery, the labs of Juliane Nguyen, PhD, professor and vice chair of pharmacoengineering and molecular pharmaceuticals at the UNC Eshelman School of Pharmacy, and Janelle Arthur, PhD, associate professor of microbiology and immunology at the UNC School of Medicine, have developed a genetically engineered probiotic strain of Saccharomyces boulardii.

Newly developed stretchable electronic skin soon might give robots and other devices the same softness and touch sensitivity as human skin. This could prove especially promising for care of the aging, where a soft touch can make a huge difference.

The new stretchable e-skin was developed by researchers at the University of Texas at Austin.

“Much like human skin has to stretch and bend to accommodate our movements, so too does e-skin,” said Nanshu Lu, PhD, a professor in the Cockrell School of Engineering’s Department of Aerospace Engineering and Engineering Mechanics who led the project. “No matter how much our e-skin stretches, the pressure response doesn’t change, and that is a significant achievement.

In an effort to improve delivery of costly medical treatments, a team of researchers in electrical engineering at the University of Wisconsin–Madison has developed a stimulating method that could make the human body more receptive to certain gene therapies.

The researchers exposed liver cells to short electric pulses — and those gentle zaps caused the liver cells to take in more than 40 times the amount of gene therapy material compared to cells that were not exposed to pulsed electric fields. The method could help reduce the dosage needed for these treatments, making them much safer and more affordable. The research appears April 30 in the journal PLOS ONE.

Dr. Melissa Grunlan is developing synthetic plugs for patients suffering from chronic knee pain or disabilities that would avoid total knee replacements.

Osteochondral defects (OCDs) can cause damage to cartilage and underlying bone, leading to chronic pain and loss of joint function. Depending on the extent of damage, individuals must undergo surgical treatment, the most extensive being total knee replacement, which over 800,000 Americans undergo each year.

Dr. Melissa Grunlan, professor in the Department of Biomedical Engineering at Texas A&M University, received a grant from the National Institute of Arthritis and Musculoskeletal and Skin Disease, a suborganization of the National Institutes of Health, to develop synthetic cartilage-capped regenerative osteochondral plugs (CC-ROPs) — a potential off-the-shelf surgical device to treat OCDs and avoid total knee replacement. 

MIT researchers find circadian variations in liver function play an important role in how drugs are broken down in the body.

Giving drugs at different times of day could significantly affect how they are metabolized in the liver, according to a new study from MIT.

Using tiny, engineered livers derived from cells from human donors, the researchers found that many genes involved in drug metabolism are under circadian control. These circadian variations affect how much of a drug is available and how effectively the body can break it down. For example, they found that enzymes that break down Tylenol and other drugs are more abundant at certain times of day.

Researchers have designed a new method for developing immunotherapy drugs using engineered peptides to elicit a natural immune response inside the body. More specifically, they showed, in antigen presenting cells, that “the hydrophobicity, electrostatic charge, and secondary conformation of helical polypeptides can be optimized to stimulate innate immune pathways via endoplasmic reticulum stress.”

In preclinical models of locally advanced and metastatic breast cancer, this method improved tumor control and prolonged survival, both as a monotherapy and in combination with immune checkpoint inhibitors.

A deep neural network-based automated detection tool could assist emergency room clinicians in diagnosing COVID-19 effectively using lung ultrasound images.

Johns Hopkins researchers have developed a deep learning-based model to detect COVID-19 infection using lung ultrasound images, according to a study published recently in Communications Medicine.

The automated detection tool uses deep neural networks (DNNs) to identify COVID-19 features in lung ultrasound B-mode images and may help clinicians diagnose emergency department patients more efficiently.

The stretchy, wireless sensor could keep patients with bladder issues informed in real-time.

For people dealing with spina bifida, paralysis, and various bladder diseases, determining when to take a bathroom break can be an issue. To help ease the frequent stress, researchers at Northwestern University have designed a sensor array that attaches to the bladder’s exterior wall, enabling it to detect its fullness in real time. Using embedded Bluetooth technology, the device then transmits its data to a smartphone app, allowing users to monitor their bodily functions without far less discomfort and guesswork.

The new tool, detailed in a study published today in the Proceedings of the National Academy of Sciences (PNAS), isn’t only meant to prevent incontinence issues. Lacking an ability to feel bladder fullness extends far beyond the obvious inconveniences—for millions of Americans dealing with bladder dysfunctions, not knowing when to go to the bathroom can cause additional organ damage such as regular infections and kidney damage. To combat these issues, the new medical device mirrors the bladder’s own elasticity.

A superior surgical sealant mimics the structural and mechanical properties of lung tissue to repair air leaks after surgery.

A new sealant meant to mimic lung tissue has been shown to rapidly cork air leaks following surgery. Moreover, the protein-like molecules within the sealant were found to potentially help with wound repair.

“Our lung-mimetic sealant is designed with a structure similar to that of the healthy lung, allowing the sealant to deform in a similar way as the breathing lung,” explained Meghan Pinezich, researcher at Columbia University in the US, and first author on the study, in an email.

In the past, artificial intelligence (AI) in healthcare was mostly in the hands of specialists — experts in marrying supercomputers to hefty hospital devices. Now, thanks to a new breed of compact, handheld AI-assisted disease-detection devices, that is changing. Healthcare AI is increasingly in the hands (and the pockets) of non-specialists.

Lightweight, battery-powered handheld healthcare AI devices made a splash in January 2024 with the arrival of a portable device for detecting skin cancer. Approved for marketing by the US Food and Drug Administration (FDA) under the brand name DermaSensor, the device looks like an oversized cellphone. It is approved for use solely by physicians, and only in patients over 40 years of age, to help in the evaluation of skin lesions suggestive of three types of skin cancer: melanoma, basal cell carcinoma and squamous cell carcinoma.

Scientists from the Massachusetts Institute of Technology (MIT) and elsewhere have published a paper in Science Advances that describes a type of nanoparticle for delivering vaccines called a metal organic framework (MOF) that can potentially provoke a strong immune response at lower doses. The paper is titled “Zeolitic Imidazolate Frameworks Activate Endosomal Toll-like Receptors and Potentiate Immunogenicity of SARS-CoV-2 Spike Protein Trimer.”

In the study, which was done in mice, the researchers showed that the MOF successfully encapsulated and delivered part of the SARS-CoV-2 spike protein while simultaneously acting as an adjuvant once it broke down inside cells. More work is needed to ensure that the particles can be used safely in human vaccines, but these early results are promising.

AI enables precision medicine with early detection of Alzheimer’s disease risk.

Researchers at the University of California, San Francisco (UCSF) recently developed an AI algorithm that can identify patients at risk for developing Alzheimer’s disease up to seven years in advance, according to a study published last week in Nature Aging.

The researchers reported that their AI models predicted Alzheimer’s disease up to seven years in advance with 72% accuracy.

The predictive capabilities of artificial intelligence (AI) machine learning are enabling disease prediction and accelerating precision medicine in an effort to improve patient outcomes. Alzheimer’s disease (AD), an incurable neurodegenerative disease, is the most common form of dementia.

Scientists from the University of California, San Diego (UCSD), and elsewhere have described a method of detecting blood-borne pathogens faster and more accurately than traditional blood cultures. The method, called digital DNA melting analysis, produces results in under six hours, much shorter than traditional cultures which can require 15 hours to several days depending on the pathogen.

Details of the method and results from a clinical pilot using blood samples from pediatric patients are provided in the Journal of Molecular Diagnostics in a paper titled, “Universal digital high resolution melt analysis for the diagnosis of bacteremia.” Results from the pilot study showed that their DNA melting approach matched results of blood cultures collected for sepsis testing. They were also able to quantify how much of the pathogen was present in the samples using DNA melting.

The National Academy of Engineering has elected UF Distinguished Professor Christine Schmidt, Ph.D., to the academy for 2024 in recognition of her more than 25 years of work to help advance the fields of neural tissue engineering and wound healing and for her leadership in diversifying bioengineering.

Election to the academy is among the highest professional distinctions bestowed upon an engineer, honoring those who have made outstanding contributions to engineering research and private industry. Schmidt, the Pruitt Family Chair in the J. Crayton Pruitt Family Department of Biomedical Engineering, is focused on creating novel materials and therapeutic systems aimed at wound healing and rebuilding peripheral and spinal nerves damaged by injuries.

Brown Engineering Dean receives one of the highest professional honors accorded an engineer.

The National Academy of Engineering (NAE) has elected Brown University Sorensen Family Dean of Engineering Tejal A. Desai to its newest membership class, honoring her distinguished contributions to engineering, “for nanofabricated materials to control biologics delivery, and leadership in the fields of nanotechnology and regenerative medicine.” Membership in the NAE is considered one of the highest professional honors accorded an engineer and Desai’s selection brings to six the number of current Brown faculty members in the NAE.

“I am deeply honored by this recognition, and am grateful for all my colleagues and trainees who have supported me over my career,” said Desai.

National Academy of Engineering Elects 114 Members and 21 International Members

The National Academy of Engineering (NAE) has elected 114 new members and 21 international members, announced NAE President John L. Anderson today. This brings the total U.S. membership to 2,310 and the number of international members to 332.

Election to the National Academy of Engineering is among the highest professional distinctions accorded to an engineer. Academy membership honors those who have made outstanding contributions to “engineering research, practice, or education, including, where appropriate, significant contributions to the engineering literature” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of engineering, or developing/implementing innovative approaches to engineering education.” Election of new NAE members is the culmination of a yearlong process. The ballot is set in December and the final vote for membership occurs during January.

Individuals in the newly elected class will be formally inducted during the NAE’s annual meeting on Sept. 29, 2024. A list of the new members and international members follows, with their primary affiliations at the time of election and a brief statement of their principal engineering accomplishments.

…

Maheshwari, Gargi, vice president, Biologics Development, Bristol Myers Squibb, Blue Bell, Pa. For industrial bioprocessing, leading to licensure of biologics and vaccines for human health.

Nancy Allbritton, the dean of the University of Washington College of Engineering and a UW professor of bioengineering, has been elected to the National Academy of Engineering, the academy announced Feb. 6.

Allbritton was selected “for innovation and commercialization of single-cell, analytical, and gut-on-chip technologies for drug screening and for engineering education.”

Drawing from the fields of engineering, chemistry, physics and materials science, Allbritton’s research develops technologies and platforms for biomedical research and clinical care, including the study and analysis of single cells for the treatment of a variety of diseases such as cancer, macular degeneration and HIV.

Deaths from breast cancer dropped 58% between 1975 and 2019 due to a combination of screening mammography and improvements in treatment, according to a new multicenter study led by Stanford Medicine clinicians and biomedical data scientists.

Nearly one-third of the decrease (29%) is due to advances in treating metastatic breast cancer —a form that has spread to other areas of in the body and is known as stage 4 breast cancer or recurrent cancer. Although these advanced cancers are not considered curable, women with metastatic disease are living longer than ever.

The analysis helps cancer researchers assess where to focus future efforts and resources.

A breakthrough study led by Dr. Mehdi Razavi at The Texas Heart Institute (THI), in collaboration with a biomedical engineering team of The University of Texas at Austin (UT Austin) Cockrell School of Engineering led by Dr. Elizabeth Cosgriff-Hernandez, sets the foundation of a ground-breaking treatment regimen for treating ventricular arrhythmia. Their study published in Nature Communications demonstrates the design and feasibility of a new hydrogel-based pacing modality.

The urgent need for an effective therapeutic regimen for ventricular arrhythmia inspired THI’s Electrophysiology Clinical Research & Innovations (EPCRI) team, led by its director, Dr. Razavi, to partner with Dr. Cosgriff-Hernandez and her UT Austin Biomedical Engineering (UT Austin BME) team to co-develop an innovative strategy that addresses the pathophysiology of re-entrant arrhythmia.

The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.

Using a new technology developed at MIT, diagnosing lung cancer could become as easy as inhaling nanoparticle sensors and then taking a urine test that reveals whether a tumor is present.

The new diagnostic is based on nanosensors that can be delivered by an inhaler or a nebulizer. If the sensors encounter cancer-linked proteins in the lungs, they produce a signal that accumulates in the urine, where it can be detected with a simple paper test strip.

UD engineers are researching and refining innovative nanomaterial-based sensors for human health applications

From keeping us warm and dry during a downpour to showcasing our Blue Hen spirit at Homecoming, clothing is essential for our comfort, protection and self-expression. But what if our clothing could do even more — what if, for example, our clothes could collect real-time data and provide feedback that could aid our recovery after an accident or surgery, or monitor our form or body posture during exercise and sports to prevent injury?

At the University of Delaware, a team of researchers from the College of Engineering has developed nanomaterial sensors that can measure precise changes in human movement while being both comfortable and cost effective. Now, thanks to funding from the National Science Foundation’s (NSF) Partnerships for Innovation (PFI) program, the team will continue studying these innovative materials while collaborating with industry partners to explore new commercial opportunities in health-related applications.

University of Connecticut Professor of Biomedical Engineering Liisa Kuhn credits Willy Wonka’s Everlasting Gobstopper for inspiring her work on designing bone grafts, growth plate repair gel—and most recently—breast prosthetics.

“The Gobstopper candy has all these layers, and each layer lets them experience a different course of a meal,” says Kuhn, who has a dual appointment with the School of Dental Medicine and the College of Engineering. “Similarly, in my own research, I’m working with multilayered structures that provide timed release of multiple factors to improve bone and cartilage healing.”

With his election, Ameer joins a group of fewer than 500 biomaterials scientists worldwide

Northwestern Engineering’s Guillermo A. Ameer has been elected a Fellow of Biomaterials Science and Engineering (FBSE) by the International Union of Societies for Biomaterials Science and Engineering (IUSBSE), the highest honor the global biomaterials community can bestow on outstanding scientists. With his election, Ameer joins a group of fewer than 500 biomaterials scientists worldwide who have been named a FBSE.

Ameer will be formally inducted May 27 at the World Biomaterials Congress in Daegu, South Korea. Fellowships recognize those who have gained a status of excellent professional standing and high achievements in the field of biomaterials science and engineering.

Cancer nanomedicine showcased at the White House Demo Day

On November 7, a team from the Marble Center for Cancer Nanomedicine showed a Washington D.C. audience several examples of how nanotechnologies developed at MIT can transform the detection and treatment of cancer and other diseases.

The team was one of 40 innovative groups featured at “American Possibilities: A White House Demo Day.” Technology on view spanning energy, artificial intelligence, climate, and health, highlighting advancements that contribute to building a better future for all Americans.

CT was shown to be the first and most effective way of reducing lung cancer mortality,’ says UCLA Health’s Dr. Denise Aberle.

Most people at greatest risk of lung cancer are overlooking a non-invasive screening that can detect cases early, when treatment can best save lives.

November marks Lung Cancer Awareness Month and UCLA Health lung cancer experts are working to spread the word about the importance of low-dose computed tomography (LDCT) of the chest. The annual scan is recommended for people with a long-term history of smoking, as well as other criteria, including age.

The screening is designed to find asymptomatic cancers when they are most treatable with surgery or radiation. It also allows doctors to monitor any suspicious findings over time.

An advanced closed-loop anesthesia delivery system that monitors brain state to tailor propofol dose and achieve exactly the desired level of unconsciousness could reduce post-op side effects.

If anesthesiologists had a rigorous means to manage dosing, they could deliver less medicine, maintaining exactly the right depth of unconsciousness while reducing postoperative cognitive side effects in vulnerable groups like the elderly. But with myriad responsibilities for keeping anesthetized patients alive and stable as well as maintaining their profoundly unconscious state, anesthesiologists don’t have the time without the technology.

To solve the problem, researchers at The Picower Institute for Learning and Memory at MIT and Massachusetts General Hospital (MGH) have invented a closed-loop system based on brain state monitoring that accurately controls unconsciousness by automating doses of the anesthetic drug propofol every 20 seconds.

Ultrasound—a technology that uses sound waves to produce an image—is commonly used to monitor the development of a baby as it grows inside its mother. But ultrasound imaging also can be used to investigate suspicious masses of tissue and nodules that may be cancerous.

Tumors consist not only of cancer cells but also a matrix of small blood vessels, or microvessels, that cannot be seen in the images produced by conventional ultrasound machines. To solve this problem, physician-scientist Azra Alizad, M.D., and biomedical engineering scientist Mostafa Fatemi, Ph.D., teamed up at Mayo Clinic to design and study a tool that may improve the resolution of ultrasound imaging.

Investigators at the University of Texas MD Anderson Cancer Center has developed a potentially groundbreaking method for enhancing immunotherapy responses in glioblastoma by using extracellular vesicles loaded with messenger RNA (mRNA). This new approach, detailed in Nature Communications, has solved some of the hurdles faced by mRNA-based therapy approaches for cancer and could lead to wider use of these therapies across a range of hard-to-treat tumor types.

The new approach for mRNA delivery builds on research from a team at MD Anderson led by Betty Kim, MD, PhD, and Wen Jiang, MD, PhD, who developed a novel method earlier this year of loading mRNA into extracellular vesicles and demonstrates the anti-tumor potential of this method of therapeutic delivery. Researchers have known for some time the therapeutic potential of mRNA to fight both infectious diseases and cancer. But methods to deliver it accurately to where it is needed has been a challenge, with various other potential delivery method studied previously including via lipid polymeric nanoparticles.

Scientists at the University of California (UC), San Diego, have developed an experimental vaccine that could curb the spread of metastatic cancers to the lungs. The key ingredients of the vaccine are nanoparticles that have been engineered to target a protein known to play a central role in cancer growth and spread. The vaccine significantly reduced the spread of metastatic breast and skin cancers to the lungs in mice. It also improved the survival rate in mice with metastatic breast cancer after surgical removal of the primary tumor.

The findings were published in the Proceedings of the National Academy of Sciences in an article titled, “Viral nanoparticle vaccines against S100A9 reduce lung tumor seeding and metastasis.”

A drug that boosts strength in injured or aging mice restores connections between nerves and muscle and suggests ways to combat weakness in humans due to aging, injury or disease.

A small molecule previously shown to enhance strength in injured or old laboratory mice does so by restoring lost connections between nerves and muscle fibers, Stanford Medicine researchers have found.

The molecule blocks the activity of an aging-associated enzyme, or gerozyme, called 15-PGDH that naturally increases in muscles as they age. The study showed that levels of the gerozyme increase in muscles after nerve damage and that it is prevalent in muscle fibers of people with neuromuscular diseases.

The research is the first to show that damaged motor neurons — nerves connecting the spinal cord to muscles — can be induced to regenerate in response to a drug treatment and that lost strength and muscle mass can be at least partially regained. It suggests that, if similar results are seen in humans, the drug may one day be used to prevent muscle loss of muscle strength due to aging or disease or to hasten recovery from injury.

The National Academy of Medicine announced the election of 100 new members to join their esteemed ranks in 2023, among them five MIT faculty members and seven additional affiliates.

MIT professors Daniel Anderson, Regina Barzilay, Guoping Feng, Darrell Irvine, and Morgen Shen were among the new members. Justin Hanes PhD ’96, Said Ibrahim MBA ’16, and Jennifer West ’92, along with three former students in the Harvard-MIT Program in Health Sciences and Technology (HST) — Michael Chiang, Siddhartha Mukherjee, and Robert Vonderheide — were also elected, as was Yi Zhang, an associate member of The Broad Institute of MIT and Harvard.

Election to the academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service, the academy noted in announcing the election of its new members.

The U.S. Food and Drug Administration has approved the use of sound waves to break down tumors—a technique called histotripsy—in humans for liver treatment.

Pioneered at the University of Michigan, histotripsy offers a promising alternative to cancer treatments such as surgery, radiation and chemotherapy, which often have significant side effects. Today, FDA officials awarded clearance to HistoSonics, a company co-founded in 2009 by U-M engineers and doctors for the use of histotripsy to destroy targeted liver tissue.

A human trial underway since 2021 at the U-M Rogel Cancer Center and other locations has treated patients with primary and metastatic liver tumors via histotripsy, demonstrating the technology’s ability to meet the testing’s primary effectiveness and safety targets.

Jennifer L. West, Ph.D., Dean of the School of Engineering and Applied Science at the University of Virginia, has been elected to the prestigious NATIONAL ACADEMY OF MEDICINE, one of the highest recognitions in health and medicine. The National Academy of Medicine is one of three institutions that make up the National Academies, operating under an 1863 Congressional charter signed by President Lincoln to assemble experts to advise the nation in science and technology.

“It is my honor to welcome this truly exceptional class of new members to the National Academy of Medicine,” said NAM President Victor J. Dzau. “Their contributions to health and medicine are unparalleled, and their leadership and expertise will be essential to helping the NAM tackle today’s urgent health challenges, inform the future of health care, and ensure health equity for the benefit of all around the globe.

Among the typical things you’d expect to find in a chemical engineer’s office — honorary awards, patent plaques, and books like “Environmental Analytical Chemistry” and “Introducing Chemical Engineering Thermodynamics” — Dr. Norma Alcantar’s office at the University of South Florida (USF) also showcases her love of life and teaching with books like “Intentional Integrity,” a coffee mug that reads “the influence of a good teacher can never be erased,” and a decorative plaque that reads “It’s All Gonna Be Fine.”

But hidden between the intellectual and inspirational materials, two sets of objects stand out: a series of cacti and owl collectibles. To the uninitiated, they appear to be whimsical office décor, but to those who know Alcantar, the folklore wisdom of the owl and the hardy, but elegantly designed cacti plant represent the tapestry of her life and career.

In addition to characterizing the genetic basis for different cancers, scientists are increasingly interested in the role of the epigenome in tumor development, and possible therapies that can target genes repressed by chemically modifying chromatin in cancer.

Part of what makes the epigenome an attractive target is the possibility of hitting a system of proteins involved in gene expression programming rather than a single target, according to Karmella Haynes, PhD, an assistant professor of biomedical engineering at Emory University. She and a team of scientists from Emory University and Georgia Institute of Technology have developed another potential approach for reactivating repressed tumor suppressor genes that could ultimately have implications for how solid tumors like triple-negative breast cancer (TNBC) are treated.

The award recognizes an individual who has made significant contributions to the science of biomaterials

Northwestern Engineering’s Guillermo A. Ameer has been elected the winner of the 2023 Excellence in Biomaterials Science Award, an honor given by the Surfaces in Biomaterials Foundation (SIBF).

The award, the highest given by the foundation, recognizes an individual who has made significant contributions to the biomaterials science field. Previous winners include Moderna cofounder Robert Langer (2020) and the late Northwestern professor Richard Van Duyne (1991).

Imagine using insects as a source of chemicals to make plastics that can biodegrade later — with the help of that very same type of bug. That concept is closer to reality than you might expect. Today, researchers will describe their progress to date, including isolation and purification of insect-derived chemicals and their conversion into functional bioplastics.

The researchers will present their results at the fall meeting of the American Chemical Society (ACS). ACS Fall 2023 is a hybrid meeting being held virtually and in-person Aug. 13–17, and features about 12,000 presentations on a wide range of science topics.

“For 20 years, my group has been developing methods to transform natural products — such as glucose obtained from sugar cane or trees — into degradable, digestible polymers that don’t persist in the environment,” said Karen Wooley, PhD, the project’s principal investigator.

Engineers and cancer researchers have harnessed the power of machine learning technology to predict immune-boosting proteins.

Machine learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response.

If validated in clinical trials, the technology could help scientists overcome a major hurdle to developing personalised immunotherapies and vaccines.

In a new study, investigators from Johns Hopkins Biomedical Engineering, the Johns Hopkins Institute for Computational Medicine, the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy show that their deep learning method, called BigMHC, can identify protein fragments on cancer cells that elicit a tumour cell-killing immune response, an essential step in understanding response to immunotherapy and in developing personalised cancer therapies.

Investigators led by Shana Kelley, PhD, the Neena B. Schwartz Professor of Chemistry, Biomedical Engineering, and of Biochemistry and Molecular Genetics, have developed a novel approach for identifying sequences of artificial DNA with differing levels of binding to other small molecules.

The approach, detailed in a study published in Nature Chemistry, could help improve the efficiency of diagnostic monitoring for patients with chronic diseases.

Aptamers are sequences of artificial DNA that selectively bind to other small molecules such as peptides, carbohydrates and foreign pathogens. Aptamers can be used for therapeutic purposes in the same way as monoclonal antibodies, and have been used for pathogen and cancer recognition as well as stem cell markers.

The discovery by scientists from Scripps Research and Cardiff University paves the way for clinical trials that use patients’ own cells to treat Parkinson’s disease

Scientists from Scripps Research and Cardiff University made key discoveries in support of a new stem cell-based therapy for Parkinson’s disease. The approach, called an autologous therapy, uses induced pluripotent stem cells (iPSCs)—made from a patient’s own skin or blood cells—to replace the neurons in the brain that are lost in Parkinson’s. Transplants of a person’s own cells eliminates the need for immunosuppression.

In a new study, the researchers used iPSCs made from the skin cells of two people with Parkinson’s disease to make young neurons that were successfully transplanted into a rat model with the disease. They used the animal model to pinpoint exactly at what stage of development the iPSC-derived neurons should be transplanted to become mature neurons that can reverse signs of disease in the rat brain.

Distinctive EEG patterns indicate when a patient’s state of unconsciousness under general anesthesia is more profound than necessary.

When patients undergo general anesthesia, their brain activity often slows down as they sink into unconsciousness. Higher doses of anesthetic drugs can induce an even deeper state of unconsciousness known as burst suppression, which is associated with cognitive impairments after the patient wakes up.

A new study from MIT, in which the researchers analyzed the EEG patterns of patients under anesthesia, has revealed brain wave signatures that could help anesthesiologists determine when patients are transitioning into that deeper state of unconsciousness. This could enable them to prevent patients from falling into that state, reducing the risk of postoperative brain dysfunction.

New research is offering some hope in the fight against pancreatic cancer.

The answer is nuclear medicine. And the power to find cancer and deliver therapy all at the same time. Theranostics, combining therapy and diagnostics, is a promising approach to cancer treatment.

While some people fear the idea of using radioactive isotopes as a therapy in the body, Julie Sutcliffe PhD. knows the power for good.

“You have a molecule, same molecule with a different piece of radioactivity on it, so one is for imaging for diagnostics, one is for therapy for treatment,” she said. “So theranostics combine the two words together.”

Rice engineers show low-cost, point-of-care platform is effective for HPV testing

Rice University bioengineers have demonstrated a low-cost, point-of-care DNA test for HPV infections that could make cervical cancer screening more accessible in low- and middle-income countries where the disease kills more than 300,000 women each year.

HPV, a family of viruses, infects nearly everyone at some point in their lives, often without symptoms. But more than a dozen types of HPV can cause persistent infections that result in cervical cancer, which is preventable and curable if it is detected early and managed effectively.

Nine engineers from the laboratory of Rice Professor Rebecca Richards-Kortum spent more than two years developing a DNA testing platform that combines two technologies, isothermal DNA amplification and lateral flow detection, in a way that greatly simplifies the equipment needs and procedures for testing.

The field of bone implants has taken incredible strides thanks to technological innovations that allow for stronger grafts that are easier to install.

Yet even with these advances, there are still risks involved in such procedures. Implants can be loosened following operations, for example, which can lead to costly surgical revisions that lengthen the recovery process for patients.

New research from an interdisciplinary team from Northwestern Engineering’s Center for Advanced Regenerative Engineering (CARE) and Center for Physical Genomics and Engineering (CPGE) could reduce the likelihood of these painful, expensive complications.

Researchers have shown that an automated cancer diagnostic method, which pairs cutting-edge ultrasound techniques with artificial intelligence, can accurately diagnose thyroid cancer, of which there are more than 40,000 new cases every year.

The method—deemed high-definition microvasculature imaging, or HDMI—noninvasively captures images of the tiny vessels within tumors and, based on the vessel features, automatically classifies the masses. Researchers at the Mayo Clinic College of Medicine and Science, who developed the technique, tested it on 92 patients with thyroid tumors, finding that the method could distinguish if the growths were cancerous with 89% accuracy. In a study published in the journal Cancers, the authors suggest that HDMI could potentially resolve a long-standing diagnostic challenge of assessing thyroid tumors in the clinic.

Repairing severely damaged bones is a challenge—especially the long bones of the arms and legs. Now, UConn Health scientists describe a new method in the 22 May issue of PNAS that can promote regrowth of long bones more affordably and with fewer side effects than other techniques.

Cleanly broken bones often heal without problems. But bones with smashed or missing sections are much more difficult to regenerate. Grafting across the gaps using bone from elsewhere is one way to fix them, and about 500,000 bone grafts are done in the US every year. But bone grafts alone don’t always work, and they’re quite costly. Recently, orthopedic surgeons have begun treating difficult breaks with specific human proteins that encourage bone growth, both alone and paired with grafts or scaffolds. They are used to encourage bone regrowth in spinal fusion surgeries, for example.

Researchers at the Johns Hopkins Convergence Institute and the Johns Hopkins Kimmel Cancer Center have developed a machine learning (ML) model capable of identifying molecular interactions among the cells in and around tumors.

The tool, known as SpaceMarkers, leverages spatial transcriptomics, a type of technology that helps measure gene expression within a tissue sample using the genes’ locations in cells.

The press release indicates that by understanding both these intercellular interactions in the tumor microenvironment and the molecular profiles of individual cells, researchers can gain insights into tumor progression..

Three Johns Hopkins researchers elected to National Academy of Sciences

Neuroscientist Amy Bastian, biomedical engineer Jennifer Elisseeff, astrophysicist Alex Szalay among 120 new members

Three Johns Hopkins University researchers—neuroscientist Amy Bastian, biomedical engineer Jennifer Elisseeff, and astrophysicist and computer scientist Alex Szalay—have been elected to the National Academy of Sciences in recognition of their distinguished and continuing achievements in original research.

Joining the company of some of history’s most distinguished scientists, Northwestern Engineering’s Teri W. Odom has been elected to the National Academy of Sciences (NAS).

Along with fellow Northwestern faculty members Timothy K. Earle and Richard B. Silverman, Odom was recognized for her excellence and notable contributions to their field of science. They are among the 120 new members and 23 new international members selected this year.

Slow-releasing implants are designed to reduce side effects associated with medications for pain relief of rheumatoid arthritis and osteoarthritis

For rheumatologic conditions like rheumatoid arthritis and osteoarthritis, NSAIDS are often the first line of medications used for pain relief. UConn Pharmacy researchers have discovered a way to minimize the side effects associated with the treatment and bring it to market.

Nonsteroidal anti-inflammatory drugs (NSAIDS) are widely used to relieve pain, reduce fever, and bring down inflammation. More than 30 billion doses are taken each year — making them among the most popular medications worldwide for general pain relief.

The portable instrument could increase global access to vaccines by simplifying their storage, distribution, and administration.

Researchers from the lab of Robert Langer, ScD, at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT), say they have developed a printer for microneedle patches smaller than postage stamps that penetrate the skin to deliver vaccines, including the COVID-19 mRNA vaccine.

The research article, “A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines,” was published in Nature Biotechnology.

Synthetic biomarkers, bioengineered sensors that generate molecular reporters in diseased microenvironments, represent an emerging paradigm in precision diagnostics. Despite the utility of DNA barcodes as a multiplexing tool, their susceptibility to nucleases in vivo has limited their utility. Here we exploit chemically stabilized nucleic acids to multiplex synthetic biomarkers and produce diagnostic signals in biofluids that can be ‘read out’ via CRISPR nucleases. The strategy relies on microenvironmental endopeptidase to trigger the release of nucleic acid barcodes and polymerase-amplification-free, CRISPR-Cas-mediated barcode detection in unprocessed urine. Our data suggest that DNA-encoded nanosensors can non-invasively detect and differentiate disease states in transplanted and autochthonous murine cancer models. We also demonstrate that CRISPR-Cas amplification can be harnessed to convert the readout to a point-of-care paper diagnostic tool. Finally, we employ a microfluidic platform for densely multiplexed, CRISPR-mediated DNA barcode readout that can potentially evaluate complex human diseases rapidly and guide therapeutic decisions.

Codon compiles Python code to run more efficiently and effectively while allowing for customization and adaptation to various domains.

In 2018, the Economist published an in-depth piece on the programming language Python. “In the past 12 months,” the article said, “Google users in America have searched for Python more often than for Kim Kardashian.” Reality TV stars, be wary.

The high-level language has earned its popularity, too, with legions of users flocking daily to the language for its ease of use due in part to its simple and easy-to-learn syntax. This led researchers from MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL) and elsewhere to make a tool to help run Python code more efficiently and effectively while allowing for customization and adaptation to different needs and contexts. The compiler, which is a software tool that translates source code into machine code that can be executed by a computer’s processor, lets developers create new domain-specific languages (DSLs) within Python — which is typically orders of magnitude slower than languages like C or C++ — while still getting the performance benefits of those other languages.

“This is the equivalent of having a wearable health sensor on your body that tells you in real time what’s happening. Think of it as a wearable for the soil,” Dr. Shalini Prasad said.

Soil quality isn’t just a concern for farmers and policymakers—it also matters on a personal level. The health of our soil affects everything from the food we eat to the air we breathe. But thanks to bioengineers at UT Dallas, new soil sensors could help improve soil productivity on a global scale.

Bioengineers at the University of Texas at Dallas have developed sensors that monitor multiple soil parameters, including total soil carbon, to provide farmers with accurate, real-time, continuous data to improve soil health and productivity.

A new AI model may signal a ‘paradigm shift’ in traumatic brain injury research by more accurately modeling the tissue deformations that lead to brain damage.

Stanford University researchers are leveraging artificial intelligence (AI) to help identify which computational models perform best at modeling mechanical stress on the brain, which may help drive insights into why some traumatic brain injuries (TBIs) lead to long-term brain damage while others do not.

The press release states that the ability to model the mechanical forces causing the compression, stretching, twisting, and other deformations of brain tissue that lead to brain damage is critical to understanding TBI. This modeling could help researchers understand why some TBIs lead to lasting brain damage and some don’t.

Northwestern Engineering researchers have developed a first-of-its-kind small, flexible, stretchable bandage that accelerates healing by delivering electrotherapy directly to the wound site. 

In an animal study, the new bandage healed diabetic ulcers 30 percent faster than in mice without the bandage. 

The bandage also actively monitors the healing process and then harmlessly dissolves — electrodes and all — into the body after it is no longer needed. The new device could provide a powerful tool for patients with diabetes, whose ulcers can lead to various complications, including amputated limbs or even death.

The brain floats in a sea of fluid that cushions it against injury, supplies it with nutrients and carries away waste. Disruptions to the normal ebb and flow of the fluid have been linked to neurological conditions including Alzheimer’s disease and hydrocephalus, a disorder involving excess fluid around the brain.

Researchers at Washington University School of Medicine in St. Louis created a new technique for tracking circulation patterns of fluid through the brain and discovered, in rodents, that it flows to areas critical for normal brain development and function. Further, the scientists found that circulation appears abnormal in young rats with hydrocephalus, a condition associated with cognitive deficits in children.

Election recognizes outstanding contributions to engineering research, practice or education

Two Ohio State University professors and a recently retired faculty member have been elected to the National Academy of Engineering (NAE) Class of 2023 in recognition of sustained excellence in innovation and education.

Alan Luo, Judit E. Puskas and Longya Xu are among 124 new NAE members, bringing the total U.S. membership to 2,420 and the number of international members to 319.

Melody Swartz, William B. Ogden Professor at the University of Chicago’s Pritzker School of Molecular Engineering (PME), has been elected to the National Academy of Engineering (NAE) for her research into lymphatic transport and immunobiology, informing novel approaches for cancer immunotherapy and vaccination.

Election to the National Academy of Engineering is among the highest professional distinctions for engineers. Academy membership honors those who have made outstanding contributions to engineering research, practice, or education, particularly as it relates to developing fields of technology or advancements in traditional fields of engineering.

Laurie E. Locascio, under secretary of commerce for standards and technology and director of the National Institute of Standards and Technology (NIST), has been elected to the National Academy of Engineering — one of the highest professional distinctions accorded to an engineer. 

Locascio leads NIST’s collaborative efforts with industry, academia and government to unleash U.S. innovation by advancing technology, measurements and standards. A key priority for her is the successful implementation of the CHIPS for America initiative, a $50 billion suite of programs to strengthen and revitalize U.S. leadership in semiconductor research, development and manufacturing. 

On February 7th, the National Academy of Engineering (NAE) elected Delta Electronics Professor of Electrical Engineering and Computer Science at MIT and CSAIL member Regina Barzilay as a new member. The NAE recognized Barzilay for her work on machine learning models that understand structures in text, molecules, and medical images, choosing members who are “pioneering new and developing fields of technology, making major advancements in traditional fields of engineering, or developing/implementing innovative approaches to engineering education.”

Her election caps off a remarkable decade of work. After being diagnosed with breast cancer in 2014, Barzilay shifted much of her efforts toward cancer research. Three years later, she developed a machine learning model that could have diagnosed her cancer earlier. In 2018, she helped launch the Jameel Clinic, which has since initiated machine learning efforts on COVID-19, different forms of cancer, Parkinson’s, and other diseases.

The National Academy of Engineering (NAE) has elected 106 new members and 18 international members, announced NAE President John L. Anderson today. This brings the total U.S. membership to 2,420 and the number of international members to 319.

Election to the National Academy of Engineering is among the highest professional distinctions accorded to an engineer. Academy membership honors those who have made outstanding contributions to “engineering research, practice, or education, including, where appropriate, significant contributions to the engineering literature” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of engineering, or developing/implementing innovative approaches to engineering education.

When noninvasive sound waves break apart tumors, they trigger an immune response in mice. By breaking down the cell wall “cloak,” the treatment exposes cancer cell markers that had previously been hidden from the body’s defenses, researchers at the University of Michigan have shown.

The technique developed at Michigan, known as histotripsy, offers a two-prong approach to attacking cancers: the physical destruction of tumors via sound waves and the kickstarting of the body’s immune response. It could potentially offer medical professionals a treatment option for patients without the harmful side effects of radiation and chemotherapy.

Gel-like materials that can be injected into the body hold great potential to heal injured tissues or manufacture entirely new tissues. Many researchers are working to develop these hydrogels for biomedical uses, but so far very few have made it into the clinic.

To help guide in the development of such materials, which are made from microscale building blocks akin to squishy LEGOs, MIT and Harvard University researchers have created a set of computational models to predict the material’s structure, mechanical properties, and functional performance outcomes. The researchers hope that their new framework could make it easier to design materials that can be injected for different types of applications, which until now has been mainly a trial-and-error process.

Oral cancer is a globally prevalent disease with an astonishingly low five-year survival rate of less than 50%. A key factor for its poor prognosis is delayed diagnosis resulting in more late-stage oral cancers. At these later stages, treatment becomes less effective and harsher on the body. Hence, many scientists aim to develop and improve diagnostic techniques for the early detection of oral cancer. At present, the gold standard for the diagnosis of most oral cancers is biopsy of suspicious oral lesions and pathologic analysis of the extracted small amounts of tissue. However, it is extremely important that clinicians biopsy the areas within the abnormal lesion with the worst disease. Currently, the decision whether or not to perform a biopsy, and the optimal biopsy site, are based on clinical examination, which greatly depends upon the experience of the examining clinician. To help identify high-risk regions, clinicians can also use commercially available imaging techniques based on autofluorescence to detect abnormal tissue at the macroscopic level, although current autofluorescence technologies suffer from low specificity for neoplastic disease.

Scientists at the University of Toronto have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine learning algorithms to accelerate drug formulation could reduce the time and cost associated with drug development, making promising new medicines available faster.

The study was published today in Nature Communications and is one of the first to apply machine learning techniques to the design of polymeric long-acting injectable drug formulations.

Researchers in the United States and Japan have discovered a new mechanism that links age-related cartilage tissue stiffening with the repression of a key protein associated with longevity. These findings enhance the understanding of mechanisms that lead to the deterioration of joints that causes osteoarthritis, according to the authors of a new study, published January 10th in Nature Communications.

In the study, researchers showed that increased stiffening of the extracellular matrix – a network of proteins and other molecules that surround and support tissues in the body – led to a decrease in a so-called “longevity protein” called Klotho (α-Klotho) in knee cartilage brought about by epigenetic changes. This Klotho decrease then damaged the cells in healthy cartilage called chondrocytes. Conversely, exposing aged chondrocytes to a softer extracellular matrix restored the knee cartilage to a more youthful state.

Harriet Nembhard, dean of the University of Iowa’s College of Engineering, has been named president of Harvey Mudd College, a liberal arts college specializing in science, engineering, and mathematics located in Claremont, California.

Nembhard, who joined Iowa in June 2020, will begin her new position July 1. The UI will conduct a national search for Nembhard’s replacement.

“I congratulate Dean Nembhard and wish her the best of luck in her new role,” says Executive Vice President and Provost Kevin Kregel. “Under her leadership, the College of Engineering has continued to build upon its exceptional research reputation while advancing equity and inclusion in STEM education. She leaves the college in a strong position moving forward.

Esteemed engineer to travel the world to advance science and technology cooperation with U.S.

LaShanda Korley, Distinguished Professor of Materials Science and Engineering and Chemical and Biomolecular Engineering at the University of Delaware, has been appointed a U.S. Science Envoy for 2023. The announcement was made by the U.S. Department of State on Tuesday, Dec. 6.

Through the Science Envoy Program, eminent U.S. scientists and engineers leverage their expertise and networks to forge connections and identify opportunities for sustained international cooperation, championing innovation and demonstrating America’s scientific leadership and technical ingenuity.

As friends and families are beginning to plan holiday gatherings, a new study found that raising the humidity level could be another mitigation method to reduce COVID-19. That sweet spot looks to be between 40% and 60% humidity.

Researchers from Massachusetts Institute of Technology (MIT) combined population-based COVID-19 data with meteorologic measurements from 121 countries collected between January and August 2020 (J R Soc Interface 2022;19[196]:20210865). Countries included had reported at least 50 COVID-19–related deaths, indicating at least one outbreak had occurred. The researchers processed the epidemiological data while accounting for bias, and developed a computational workflow to estimate indoor conditions based on outdoor weather data and standard indoor comfort conditions.

While diabetes is already associated with an increased risk of developing breast cancer, a new Vanderbilt study published in Science Advances on November 18 indicates that presence of the disease may increase tumor growth and stiffness.

Researchers also found that diabetes treatments could reduce the tumor growth and stiffness to levels comparable with non-diabetic ones. The research was led by Cynthia Reinhart-King, Cornelius Vanderbilt Professor of Engineering and University Distinguished Professor. Vanderbilt Ph.D. student Wenjun Wang, a current member of Reinhart-King’s cellular mechanics lab, and Lauren Hapach, PhD’21, a former lab member, were co-authors.

Scientists hypothesize that, as in a hibernating turtle, the brain under sedation and deprived of oxygen may assume a protective state.

Many Covid-19 patients who have been treated for weeks or months with mechanical ventilation have been slow to regain consciousness even after being taken off sedation. A new article in the Proceedings of the National Academy of Sciences offers the hypothesis that this peculiar response could be the effect of a hibernation-like state invoked by the brain to protect cells from injury when oxygen is scarce.

A very similar kind of state, characterized by the same signature change of brain rhythms, is not only observed in cardiac arrest patients treated by chilling their body temperature, a method called “hypothermia,” but also by the painted turtle, which has evolved a form of self-sedation to contend with long periods of oxygen deprivation, or “anoxia,” when it overwinters underwater.

Muscle stem cells, the cells in muscle fibers that generate new muscle cells after injury or exercise, lose their potency with age. But a study by researchers at Stanford Medicine shows that old mice regain the leg muscle strength of younger animals after receiving an antibody treatment that targets a pathway mediated by a molecule called CD47.

The findings are surprising because CD47, billed as the “don’t eat me” molecule, is better known as a target for cancer immunotherapy than for muscle regeneration. It peppers the surface of many cancer cells, protecting them from immune cells that patrol the body to root out and engulf dysfunctional or abnormal cells. Now it seems old muscle stem cells may use a similar approach to avoid being culled by the immune system.

Exploratory collaboration will focus on developing strategies using 3-D printed bioscaffolds to support the growth and maturation of ovarian follicles to produce fertilizable eggs

Newswise — Dimension Inx, a regenerative biomaterials company, and Ann & Robert H. Lurie Children’s Hospital of Chicago have been jointly awarded an NIH Exploratory/Developmental Research Grant. The grant focuses on uncovering a novel approach to in vitro growth and maturation (IVGM) of ovarian follicles. Together, Dimension Inx and Lurie Children’s will use the funding to further explore the development of a more accessible and affordable infertility preservation intervention, one particularly useful in the emerging field of oncofertility.

Infertility is a significant and growing global health problem, with estimates suggesting more than 186 million individuals live with infertility worldwide. While assistive reproductive technologies (ART) methods like IVF have been available for over four decades, these technologies remain largely inaccessible and unaffordable.